TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

Core Insights - TELA Bio, Inc. has launched larger sizes of the OviTex PRS Reinforced Tissue Matrix, specifically designed for plastic and reconstructive surgery, enhancing its product offerings in the market [1][3] - The new sizes include a 25 x 30 cm oval and a 25 cm diameter circle, which may simplify complex surgical procedures by reducing the need for multiple smaller pieces [2][3] - Since its launch in 2019, TELA Bio has sold nearly 15,000 units of OviTex PRS, with a year-over-year unit sales growth of 31% in 2024, indicating strong market demand [3] Company Overview - TELA Bio, Inc. is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions, aiming to optimize clinical outcomes while preserving the patient's anatomy [4] - The company emphasizes the importance of providing advanced and economically effective solutions that leverage the patient's natural healing response [4] Product Information - OviTex PRS is intended for implantation to reinforce soft tissue in patients requiring repair or reinforcement in plastic and reconstructive surgery, supplied sterile for one-time use [5]